SUPN · Company research
Supernus Pharmaceuticals, Inc. (SUPN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Supernus Pharmaceuticals Inc (SUPN) Shares Surge 5.2% -- What GF Score of 84 Tells Investors - GuruFocus | Supernus Pharmaceuticals Inc (SUPN) Shares Surge 5.2% -- What GF Score of 84 Tells Investors GuruFocus | View source ↗ | GuruFocus | Oct 19, 2026 | neutral | 0 | 0.6 |
| The results webcast will be available for 60 days after Supernus' Oct. 29 call. - Stock Titan | The results webcast will be available for 60 days after Supernus' Oct. 29 call. Stock Titan | View source ↗ | Stock Titan | Oct 19, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts - Yahoo Finance Australia | Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 19, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts - Yahoo Finance | Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts - Yahoo Finance UK | Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals (NasdaqGM:SUPN) Stock Forecast & Analyst Predictions - Simply Wall Street | Supernus Pharmaceuticals (NasdaqGM:SUPN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 15, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts - Yahoo! Finance Canada | Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts - Yahoo Finance | Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals, Inc. (SUPN) Stock Price, News, Quote & History - Yahoo! Finance Canada | Supernus Pharmaceuticals, Inc. (SUPN) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| A $1B Indivior dividend factors into Supernus (SUPN) proposed merger valuations. - Stock Titan | A $1B Indivior dividend factors into Supernus (SUPN) proposed merger valuations. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| 3 Reasons SUPN is Risky and 1 Stock to Buy Instead - Yahoo Finance | 3 Reasons SUPN is Risky and 1 Stock to Buy Instead Yahoo Finance | View source ↗ | Yahoo Finance | Sep 21, 2026 | neutral | 0 | 0.6 |
| SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Super - The National Law Review | SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Super The National Law Review | View source ↗ | The National Law Review | Aug 29, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals (SUPN) Stock May Be A Bargain After Merger News - Yahoo Finance | Supernus Pharmaceuticals (SUPN) Stock May Be A Bargain After Merger News Yahoo Finance | View source ↗ | Yahoo Finance | Aug 11, 2026 | neutral | 0 | 0.6 |
| SUPN vs. TEVA: Which Stock Should Value Investors Buy Now? - Yahoo Finance | SUPN vs. TEVA: Which Stock Should Value Investors Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 7, 2026 | neutral | 0 | 0.6 |
| Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company - MedCity News | Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company MedCity News | View source ↗ | MedCity News | Aug 3, 2026 | neutral | 0 | 0.6 |
| Why Supernus Pharmaceuticals Stock Topped the Market Today - The Motley Fool | Why Supernus Pharmaceuticals Stock Topped the Market Today The Motley Fool | View source ↗ | The Motley Fool | Aug 3, 2026 | neutral | 0 | 0.6 |
| Supernus and Indivior Agree to All-Stock Merger of Equals - Stock Titan | Supernus and Indivior Agree to All-Stock Merger of Equals Stock Titan | View source ↗ | Stock Titan | Aug 3, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals (NASDAQ:SUPN) Surprises With Q2 CY2026 Sales, Stock Jumps 24.9% - StockStory | Supernus Pharmaceuticals (NASDAQ:SUPN) Surprises With Q2 CY2026 Sales, Stock Jumps 24.9% StockStory | View source ↗ | StockStory | Aug 3, 2026 | neutral | 0 | 0.6 |
| 3 of Wall Street’s Favorite Stocks We Approach with Caution - StockStory | 3 of Wall Street’s Favorite Stocks We Approach with Caution StockStory | View source ↗ | StockStory | Jun 18, 2026 | neutral | 0 | 0.6 |
| Supernus Pharmaceuticals (SUPN) Stock Rises on Q1 2026 Earnings - Quiver Quantitative | Supernus Pharmaceuticals (SUPN) Stock Rises on Q1 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | May 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.